(Q73848274)
Statements
Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis (English)
H Ekberg
L Bäckman
G Tufveson
G Tydén
B Nashan
scientific article published on 01 January 2000